Featured image for “Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute”
04/27/2018

Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute

…How would a collaborative melanoma tissue bank consortium help advance the prevention, detection, and treatment of melanoma? A collaborative melanoma tissue…
Blog - Melanoma360
, 
Melanoma Research
Featured image for “Six-and-a-Half-Year Outcomes for Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Continue to Demonstrate Durable Long-Term Survival Benefits in Patients with Advanced Melanoma”
05/21/2021

Six-and-a-Half-Year Outcomes for Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Continue to Demonstrate Durable Long-Term Survival Benefits in Patients with Advanced Melanoma

…safety. About Melanoma Melanoma is a form of skin cancer characterized by the uncontrolled growth of pigment-producing cells (melanocytes) located…
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research
Featured image for “Castle Biosciences Awarded U.S. Federal Supply Schedule Contract for DecisionDx-Melanoma”
08/25/2021

Castle Biosciences Awarded U.S. Federal Supply Schedule Contract for DecisionDx-Melanoma

…plans that incorporate DecisionDx-Melanoma test results. Through June 30, 2021, DecisionDx-Melanoma has been ordered 78,277 times for use in patients…
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research
Featured image for “World Health Organization Predicts Half a Million With Melanoma in 2040”
06/13/2024

World Health Organization Predicts Half a Million With Melanoma in 2040

Without intervention today, the number of people affected by melanoma will skyrocket. The World Health Organization warns that new diagnoses…
Blog - Melanoma360
Featured image for “In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma”
11/16/2022

In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma

By Kim Margolin, M.D., FACP, FASCO Background—Immunotherapy of melanoma The explosion of immunotherapy over the past decade has revolutionized the…
Blog - Melanoma360
, 
In Plain English
Featured image for “In Plain English—June 2021 News from ASCO, the American Society of Clinical Oncology”
07/29/2021

In Plain English—June 2021 News from ASCO, the American Society of Clinical Oncology

…great potential in combination with nivolumab and to be most effective as the first treatment of metastatic melanoma. This study…
Blog - Melanoma360
, 
In Plain English
Featured image for “AIM at Melanoma Opens the Second Branch of Fresh Frozen Primary Tissue Bank at Sutter’s California Pacific Medical Center”
09/09/2019

AIM at Melanoma Opens the Second Branch of Fresh Frozen Primary Tissue Bank at Sutter’s California Pacific Medical Center

…for melanoma while improving the lives of those it affects. AIM’s global research initiatives include The International Melanoma Tissue Bank…
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research
Featured image for “Spinning For Melanoma”
04/30/2021

Spinning For Melanoma

…accelerate the quest for the cure. Val’s drive came from her daughter Charlie’s death from melanoma at 26 years old.…
Blog - Melanoma360
, 
Friends, Family, & Caregivers
, 
Philanthropy
Featured image for “In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma”
04/11/2024

In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma

…forms of immunotherapy.  Additionally, because melanoma is so resistant to chemotherapy and radiation, the relative benefits of immunotherapy are greater…
Blog - Melanoma360
, 
In Plain English
, 
Melanoma Research
Featured image for “AIM at Melanoma Opens the Fourth Branch of Fresh Frozen Primary Tissue Bank at Robert H. Lurie Comprehensive Cancer Center of Northwestern University”
01/23/2020

AIM at Melanoma Opens the Fourth Branch of Fresh Frozen Primary Tissue Bank at Robert H. Lurie Comprehensive Cancer Center of Northwestern University

…The International Melanoma Tissue Bank Consortium, The Melanoma International Collaboration for Adaptive Trials, and the International Melanoma Working Group. AIM…
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research

Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute

…How would a collaborative melanoma tissue bank consortium help advance the prevention, detection, and treatment of melanoma? A collaborative melanoma tissue…
Featured image for “Q&A with Omid Hamid, MD, Director of the Melanoma Center and Phase I Immuno-Oncology Program at The Angeles Clinic and Research Institute”
Blog - Melanoma360
, 
Melanoma Research

Six-and-a-Half-Year Outcomes for Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Continue to Demonstrate Durable Long-Term Survival Benefits in Patients with Advanced Melanoma

…safety. About Melanoma Melanoma is a form of skin cancer characterized by the uncontrolled growth of pigment-producing cells (melanocytes) located…
Featured image for “Six-and-a-Half-Year Outcomes for Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Continue to Demonstrate Durable Long-Term Survival Benefits in Patients with Advanced Melanoma”
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research

Castle Biosciences Awarded U.S. Federal Supply Schedule Contract for DecisionDx-Melanoma

…plans that incorporate DecisionDx-Melanoma test results. Through June 30, 2021, DecisionDx-Melanoma has been ordered 78,277 times for use in patients…
Featured image for “Castle Biosciences Awarded U.S. Federal Supply Schedule Contract for DecisionDx-Melanoma”
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research

World Health Organization Predicts Half a Million With Melanoma in 2040

Without intervention today, the number of people affected by melanoma will skyrocket. The World Health Organization warns that new diagnoses…
Featured image for “World Health Organization Predicts Half a Million With Melanoma in 2040”
Blog - Melanoma360

In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma

By Kim Margolin, M.D., FACP, FASCO Background—Immunotherapy of melanoma The explosion of immunotherapy over the past decade has revolutionized the…
Featured image for “In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma”
Blog - Melanoma360
, 
In Plain English

In Plain English—June 2021 News from ASCO, the American Society of Clinical Oncology

…great potential in combination with nivolumab and to be most effective as the first treatment of metastatic melanoma. This study…
Featured image for “In Plain English—June 2021 News from ASCO, the American Society of Clinical Oncology”
Blog - Melanoma360
, 
In Plain English

AIM at Melanoma Opens the Second Branch of Fresh Frozen Primary Tissue Bank at Sutter’s California Pacific Medical Center

…for melanoma while improving the lives of those it affects. AIM’s global research initiatives include The International Melanoma Tissue Bank…
Featured image for “AIM at Melanoma Opens the Second Branch of Fresh Frozen Primary Tissue Bank at Sutter’s California Pacific Medical Center”
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research

Spinning For Melanoma

…accelerate the quest for the cure. Val’s drive came from her daughter Charlie’s death from melanoma at 26 years old.…
Featured image for “Spinning For Melanoma”
Blog - Melanoma360
, 
Friends, Family, & Caregivers
, 
Philanthropy

In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma

…forms of immunotherapy.  Additionally, because melanoma is so resistant to chemotherapy and radiation, the relative benefits of immunotherapy are greater…
Featured image for “In Plain English: Tumor-Infiltrating Lymphocyte (“TIL”) Therapy for Advanced Melanoma”
Blog - Melanoma360
, 
In Plain English
, 
Melanoma Research

AIM at Melanoma Opens the Fourth Branch of Fresh Frozen Primary Tissue Bank at Robert H. Lurie Comprehensive Cancer Center of Northwestern University

…The International Melanoma Tissue Bank Consortium, The Melanoma International Collaboration for Adaptive Trials, and the International Melanoma Working Group. AIM…
Featured image for “AIM at Melanoma Opens the Fourth Branch of Fresh Frozen Primary Tissue Bank at Robert H. Lurie Comprehensive Cancer Center of Northwestern University”
Blog - Melanoma360
, 
Breaking News
, 
Melanoma Research

Recent Posts

Featured image for “The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public”
Jun. 09, 2026

The FDA Just Approved a New Sunscreen Ingredient— What It Means for Patients with Skin Cancer, Survivors, and the General Public

Featured image for “Fifth Annual Evening in Memory of Valerie Guild”
Jun. 05, 2026

Fifth Annual Evening in Memory of Valerie Guild

Featured image for “Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective ”
Jun. 05, 2026

Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective 

Featured image for “Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes”
Jun. 05, 2026

Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes

Featured image for “Promising early results with imneskibart, low-dose subcutaneous IL-2, and nivolumab in patients who do not respond to or who relapse after receiving combination checkpoint inhibitors”
Jun. 05, 2026

Promising early results with imneskibart, low-dose subcutaneous IL-2, and nivolumab in patients who do not respond to or who relapse after receiving combination checkpoint inhibitors

Filter by Tag